Season 1, Episode 12: The Future of Immuno-Oncology with Mark Frohlich

Michael Pietrack sits down with Mark Frohlich, a Harvard-trained medical Oncologist and CEO of Indapta Therapeutics! He discusses his experience in the Pharmaceutical industry as a pioneer in Immuno-Oncology. He emphasizes the importance of understanding the immune system and the integration of…

May 27^th • 19 mins listen